14 cases [24.1%]). All children were exclusively formula-fed. No child received blood or blood products.
Hepatitis G virus (HGV), also called hepatitis virus GB-C ters for Disease Control and Prevention (CDC) criteria [12] . The or GB virus C, is a positive-stranded RNA agent. It presents CDC classification for HIV-1 infection in adults was used to define a genomic organization common to that of the Flaviviridae the mothers' clinical condition at the time of delivery [13] . Positivfamily and conserved sequences but has õ25% homology with ity for HGV RNA defined an HGV infection [1, 2] . Exposure to hepatitis C virus (HCV). [1] . Serum HGV RNA indicates vire-HBV was defined by positivity for HBV surface antigen (HBsAg) mia, whereas the HGV envelope E2 glycoprotein -specific antior core antigen (HBcAg) antibody.
body (E2Ab) is associated with recovery [2] . HGV RNA and Data set. Fifty-eight HIV-1-positive mothers (median age, 28.5 E2Ab are almost mutually exclusive and can be found respecyears; range, 20-37) and their children were studied. All women had tively in õ2% and 9% of healthy blood donors [1, 2] . Prevadenied prior receipt of blood or blood products. Thirty-four women lence increases in association with HCV or hepatitis B virus (58.6%; median age, 29.5 years; range, 20-37) had a history of IDU (HBV) infection [1, 3] . The main infection route is parenteral (median duration, 4.7 years; range, 2.0-9.4) and reported sharing equipment with injecting partners. Twenty-two IDU women (median exposure to blood through transfusions, hemodialysis, or sharage, 30.5 years; range, 23-37) had ceased injecting a median of 2.2 ing equipment in injecting drug use (IDU); indeed, ú30% of years (range, 0.9-12) before delivery, whereas 12 (median age, 29 transfusion recipients and up to 80% of IDUs are HGV markeryears; range, 20-36) continued injecting during pregnancy. Risky positive [1 -5] . Sexual transmission is suspected [5 -7] . HGV sexual behavior (RSB) was the sole infection route for HIV-1 in 24 and human immunodeficiency virus type 1 (HIV-1) share the women (41.3%; median age, 26 years; range, 20-35); 14 of them same infection routes, and a significant proportion of HIVreported RSB with IDU men. Fifty-six women (96.5%) were classi-1 -infected subjects are HGV-coinfected [7] . Mother-to-child fied as clinical category A and 2 as category B. Twenty children infection occurs [8 -10] reaction (PCR) [3] using two primers from the noncoding region an HBV recombinant vaccine and 0.5 mL/kg anti-HBsAg immunoglobulin (180 IU/mL) were administered within 8 h of (median age, 28.5; range, 20 -36) had E2Ab and 12 (20.6%) (median age, 29.5; range, 23 -35) were HGV-infected. No birth.
Outcome of HGV infection in children.
No HGV-infected woman was E2Ab-and RNA-positive at the same time. The E2Ab-and HGV RNA -positive subject ratio was 1.6. CD4 T child (follow-up, 16 months; range, 12 -52) became icteric or showed serum liver enzymes below the upper limit of the lymphocyte numbers did not differ in those who were HGVinfected (613 { 271 cells/mL), E2Ab-positive (711 { 307 cells/ normal range. Growth and development was normal in children who were HIV-1 -uninfected. The age and infection status at mL), or HGV marker -negative (724 { 314 cells/mL; Student's / 9d50$$se05 08-04-98 08:40:22 jinfal UC: J Infect the last follow-up and the age at HGV RNA clearance in E2Ab-HIV-1 -infected women may be at risk of a persistent HGV infection, similar to those immunocompromised patients reseroconverted children are reported in table 2.
ceiving hemodialysis [4] . An E2Ab-and HGV RNA -positive ratio of 3.6 is reported in healthy blood donors [2] , and the Discussion RNA seroprevalence decreases and the E2Ab seroprevalence HIV-1 -infected women exposed to bloodborne and sexually increases with injecting duration in IDUs with low HIV-1 prevtransmitted infections show an HGV marker seroprevalence alence [2, 5] . By contrast, the ratio is about half in HIV-1 -five times higher than in healthy blood donors [1, 2] . The infected women, and marker seroprevalence is independent effectiveness of the sexual route of infection is suggested by of injecting duration in HIV-1 -infected IDU women. CD4 T similar seroprevalence in IDU and RSB women and by the lymphocyte numbers are similar in HGV-infected women and increased risk in RSB women whose sex partners were IDUs E2Ab-positive women, but more subtle immune defects are (frequently HGV-infected [2, 5] ). Our findings comply with likely to hinder their recovery. HIV-1 -infected subjects also the results of seroprevalence studies in other groups at risk have difficulty in HCV infection control, independent of CD4 [5 -8] and are also supported by the presence of HGV in other T lymphocyte numbers [15] . body fluids in addition to blood [8] . HCV, but not HBV and Our study indicates that the HGV transmission rate in HIV-HGV, exposure is significantly associated with a history of 1 -infected mothers is higher than that of HIV-1 or HCV. It is IDU and supports the HGV sexual transmission mechanism. also presumably higher than that in normally immune-compe-HCV (unlike HBV) is seldom sexually transmitted [5, 6] , and tent women [8] . Whether transmission relates to HGV maternal a history of parenteral blood exposure is uncommon in HGVvirus load or not will be the aim of further studies, and monitorand HCV-uninfected subjects [3] . As a synergic interrelationing at-risk women during pregnancy could indicate whether ship may exist between HIV-1 and sexually transmitted infecprimary infection favors transmission of the virus. tions [14] , an HIV-1 -related immune defect may favor an
In the case of a bloodborne infection, HGV RNA becomes positive within 2 weeks of transfusion [3] . In HGV-infected HGV sexual infection. 
